Clinical Trial Update: Study Comparing Paclitaxel Plus Carboplatin Versus Anthracyclines Followed by Docetaxel as Adjuvant Chemotherapy for Triple Negative Breast Cancer (PATTERN) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing paclitaxel plus carboplatin versus anthracyclines followed by docetaxel as adjuvant chemotherapy for triple negative breast cancer has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• DOCETAXEL (DOCETAXEL)
• PACLITAXEL (PACLITAXEL)
• anthracyclines (anthracycline)

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED